PIPS opportunity: C4X Discovery Drug Target Identification Intern

3 months, based in London or Manchester. Apply by 30 June

C4X Discovery aims to become the world’s most productive drug discovery and development company by exploiting cutting-edge technologies to design and create best-in-class drug candidates.  

The Company was founded in 2008 as a spin-out from the University of Manchester and has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically. 

In this project, you will make a vital contribution to real-world drug discovery programs at their initiation, helping us to decide which targets to pursue next in our pipeline. The key aim of the project is to undertake reviews of potential drug discovery targets identified either by C4X’s proprietary genetic analysis method (Taxonomy3) or from analysis of published literature. You will assess the strength of linkage to disease, the mechanism of action of existing compounds and the competitor landscape by reviewing and evaluating publicly available information in scientific journals, patents and databases. You will be exposed to target evaluation across a range of disease areas including oncology, inflammation and neurodegeneration and will be expected to regularly present your findings in both written reports and slide presentations. This is an exciting opportunity to be trained in how to conduct target reviews in the pharmaceutical industry and select the best targets for drug development – key skills sought after in today’s competitive life-sciences workplace. 

Full details here.

Start possible from mid Sep 2018, to end from mid Dec 2018, but 3 month placement in total, whenever starts. Apply to Clare.murray@c4xdiscovery.com by 30 June 2018.

published on: 30th May 2018